- Home
- SHMD vs XGN Comparison
SHMD vs XGN Comparison
Compare SHMD & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHMD
- XGN
- Stock Information
- Founded
- SHMD 1864
- XGN 2002
- Country
- SHMD Germany
- XGN United States
- Employees
- SHMD N/A
- XGN N/A
- Industry
- SHMD
- XGN Medical Specialities
- Sector
- SHMD
- XGN Health Care
- Exchange
- SHMD Nasdaq
- XGN Nasdaq
- Market Cap
- SHMD 123.6M
- XGN 138.3M
- IPO Year
- SHMD N/A
- XGN 2019
- Fundamental
- Price
- SHMD $2.70
- XGN $7.23
- Analyst Decision
- SHMD
- XGN Strong Buy
- Analyst Count
- SHMD 0
- XGN 2
- Target Price
- SHMD N/A
- XGN $7.50
- AVG Volume (30 Days)
- SHMD 23.6K
- XGN 236.6K
- Earning Date
- SHMD 02-25-2025
- XGN 08-04-2025
- Dividend Yield
- SHMD N/A
- XGN N/A
- EPS Growth
- SHMD N/A
- XGN N/A
- EPS
- SHMD N/A
- XGN N/A
- Revenue
- SHMD $85,165,542.00
- XGN $56,724,000.00
- Revenue This Year
- SHMD N/A
- XGN $19.39
- Revenue Next Year
- SHMD N/A
- XGN $13.27
- P/E Ratio
- SHMD N/A
- XGN N/A
- Revenue Growth
- SHMD N/A
- XGN 1.78
- 52 Week Low
- SHMD $1.86
- XGN $1.71
- 52 Week High
- SHMD $5.17
- XGN $7.95
- Technical
- Relative Strength Index (RSI)
- SHMD N/A
- XGN 56.74
- Support Level
- SHMD N/A
- XGN $7.10
- Resistance Level
- SHMD N/A
- XGN $7.95
- Average True Range (ATR)
- SHMD 0.00
- XGN 0.51
- MACD
- SHMD 0.00
- XGN -0.04
- Stochastic Oscillator
- SHMD 0.00
- XGN 46.67
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.